We Support Discovery Programs with Human Organ Models

We believe that human tissue models are at the very core of tomorrow’s drug discovery. Our team of world class experts in Organ-on-a-Chip modelling and screening supports decision-making from target validation through safety assessment – reducing clinical attrition and shortening timelines.

Supporting Every Phase of Pre-Clinical Drug Discovery

Our services support our clients in each phase of drug discovery

The right question
We validate fundamental disease hypotheses through interrogating real biological tissues.
Publication spotlight from Galapagos →
Relevant target
We perform target discovery and validation to make sure a target is relevant in the right context.
The 1st high-throughput organ-on-a-chip screen →
Efficacious compound
We triage compounds for efficacy in comprehensive disease models.


Explore our work with Sanofi →
The safest therapy
We assess lead candidates for toxicity.
and bioavailability.

Webinar with AstraZeneca on a peripheral neuropathy model →

Working Together, Your Way

From fast projects to multi-phase partnerships, our collaborations are designed to fit your goals. We tailor each engagement to your scientific objectives, timelines, and budget so you get exactly the support you need, when you need it.

Consultation

Understand your goals, scope, and success criteria

Study design

Select the right model setup, endpoints, and approach

Project initiation

Meet your dedicated MIMETAS scientists

Execution

Experiments performed in our state-of-the-art laboratories

Progress updates

Regular calls and interim data sharing

Final reporting

Clear summary of collected data, conclusions, and recommendations

Our Expertise for Your Research Needs

We use primary cells, organoids, and cell lines to deliver human-relevant assays. For your research, we source patient-derived materials with care and precision. In this way, we ensure every model reflects the biology that matters most to your program.

Ready to Advance Your Program?

Let’s discuss how MIMETAS can support your
drug discovery and development pipeline.